Suppr超能文献

过度的 MYC-拓扑异构酶活性会引发急性 DNA 损伤、MYC 降解,并被 p53-拓扑异构酶取代。

Excessive MYC-topoisome activity triggers acute DNA damage, MYC degradation, and replacement by a p53-topoisome.

机构信息

Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA.

Energy Storage and Technology Department, Energy and Environment Science and Technology Division, Idaho National Laboratory, Idaho Falls, ID 83415, USA.

出版信息

Mol Cell. 2024 Nov 7;84(21):4059-4078.e10. doi: 10.1016/j.molcel.2024.10.006. Epub 2024 Oct 30.

Abstract

Hyperproliferation driven by the protooncogene MYC may lead to tumor suppressor p53 activating DNA damage that has been presumed to derive from hypertranscription and over-replication. Here, we report that excessive MYC-topoisome (MYC/topoisomerase 1/topoisomerase 2) activity acutely damages DNA-activating pATM and p53. In turn, MYC is shut off and degraded, releasing TOP1 and TOP2A from MYC topoisomes in vitro and in vivo. To manage the topological and torsional stress generated at its target genes, p53 assembles a separate topoisome. Because topoisomerase activity is intrinsically DNA damaging, p53 topoisomes provoke an initial burst of DNA damage. Because p53, unlike MYC, upregulates the DNA-damage response (DDR) and activates tyrosyl-DNA-phosphodiesterase (TDP) 1 and TDP2, it suppresses further topoisome-mediated damage. The physical coupling and activation of TOP1 and TOP2 by p53 creates a tool that supports p53-target expression while braking MYC-driven proliferation in mammalian cells.

摘要

原癌基因 MYC 的过度增殖可能导致肿瘤抑制因子 p53 激活 DNA 损伤,这种损伤据推测源自过度转录和过度复制。在这里,我们报告称,过多的 MYC-拓扑异构酶(MYC/拓扑异构酶 1/拓扑异构酶 2)活性会迅速破坏激活 pATM 和 p53 的 DNA。反过来,MYC 被关闭和降解,TOP1 和 TOP2A 从 MYC 拓扑异构酶中释放出来,无论是在体外还是在体内。为了应对其靶基因产生的拓扑和扭曲应力,p53 组装了一个单独的拓扑异构酶。由于拓扑异构酶活性本质上具有 DNA 损伤性,p53 拓扑异构酶会引发最初的 DNA 损伤爆发。由于 p53 不像 MYC 那样上调 DNA 损伤反应 (DDR) 并激活酪氨酸-DNA-磷酸二酯酶 (TDP) 1 和 TDP2,因此它会抑制进一步的拓扑酶介导的损伤。TOP1 和 TOP2 由 p53 的物理偶联和激活创造了一种工具,它支持 p53 靶基因的表达,同时抑制哺乳动物细胞中 MYC 驱动的增殖。

相似文献

5
Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential.酪氨酰-DNA磷酸二酯酶抑制剂:进展与潜力
Bioorg Med Chem. 2016 Nov 1;24(21):5017-5027. doi: 10.1016/j.bmc.2016.09.045. Epub 2016 Sep 20.
6
Untangling trapped topoisomerases with tyrosyl-DNA phosphodiesterases.解开与酪氨酰-DNA 磷酸二酯酶纠缠的拓扑异构酶。
DNA Repair (Amst). 2020 Oct;94:102900. doi: 10.1016/j.dnarep.2020.102900. Epub 2020 Jun 18.
10
Mutual regulation of MDM4 and TOP2A in cancer cell proliferation.MDM4 和 TOP2A 在癌细胞增殖中的相互调控。
Mol Oncol. 2019 May;13(5):1047-1058. doi: 10.1002/1878-0261.12457. Epub 2019 Feb 4.

本文引用的文献

2
Beyond gene expression: how MYC relieves transcription stress.超越基因表达:MYC 如何缓解转录应激。
Trends Cancer. 2023 Oct;9(10):805-816. doi: 10.1016/j.trecan.2023.06.008. Epub 2023 Jul 7.
4
MYC: a complex problem.MYC:一个复杂的问题。
Trends Cell Biol. 2023 Mar;33(3):235-246. doi: 10.1016/j.tcb.2022.07.006. Epub 2022 Aug 10.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验